Promoter Sangeetha acquires 5.4956% stake from promoter Kavetha
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On 18 September 2025, promoter Sangeetha Sundaramoorthy bought 11,42,900 shares at Rs 70 each from promoter Kavetha Sundarmoorthy under a 2 June 2025 share purchase agreement. The transfer equalled 5.4956% of diluted capital, lifting Sangeetha's stake to 28.1092% and reducing Kavetha's to 9.6149%. The filing states no open offer was required.
This promoter-to-promoter transfer shifts voting power within the promoter group. It adds no shares, causes no dilution and requires no open offer.